← Evidence library

BIB_354

AMBLor IB/IIA prognostic biomarker — UKCA-marked September 2024; on NHS market.

Evidence grade

A

Tier

1 (NICE MIB + UKCA-marked product + peer-reviewed BJD validation)

Cited by tasks

01, 04, 05, 06, 15, 24

Identifiers

PMID:31056744

↗ Follow the original source for full context

Full extracted findings & patient-implication analysis: bibliography/BIB_354/findings.md (research corpus). This page is a short context summary — not individualised medical advice.